InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,642.07
(
0.48%
)
US TECH 100
19,883.80
(
0.46%
)
Dow Jones
40,168.17
(
0.42%
)
Brent Oil
84.26
(
-0.40%
)
Bitcoin
63,050.55
(
3.73%
)
Post# of 252596
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 217787

Friday, 03/16/2018 10:34:03 AM

Friday, March 16, 2018 10:34:03 AM

Post# of 252596
Mavyret’s US market share continues growth—week ending 3/9/18 (according to IMS):

• ABBV/ENTA’s NRx share=43.1%, the highest-ever weekly figure, blowing past the previous high of 39.6% in the preceding week.

• ABBV/ENTA’s TRx share=38.2%, also the highest-ever weekly figure, up from the previous high of 35.1% in the preceeding week.

(Almost all of ABBV/ENTA’s US HCV business now comes from Mavyret.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up